Keywords: xoma, initiate, ph, ii, trial, diabetes, mab

Xoma to initiate Ph II trial of diabetes MAb

Article | 22 December 2008

Print This

US drug developer Xoma plans to initiate a Phase II trial of its antibody drug candidate, XOMA 052, for the treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in